Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1057-1060
© 2000 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
C-Reactive Protein, Cardiovascular Risk Factors, and Mortality in a Prospective Study in the Elderly
Presented in part in abstract form at the 39th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, American Heart Association, Orlando, Fla, March 24–27, 1999.
From the Department of Medicine, University of Helsinki, Helsinki, Finland.
Abstract—Serum C-reactive protein (CRP) reflects inflammation and predicts cardiovascular disease in middle-aged individuals. We investigated CRP, risk factors, and 10-year mortality in 3 elderly cohorts (aged 75, 80, and 85 years; n=455) of the population-based Helsinki Ageing Study. Clinical and laboratory examinations were performed at baseline, and in 1998, CRP was measured by a sensitive method (sensitivity 0.3 mg/L) from frozen serum samples. Mortality data were retrieved from national registers. Serum CRP ranged from 0.18 to 170.0 mg/L (interquartile range 0.68 to 4.10 mg/L, median 1.60 mg/L). CRP correlated significantly with body mass index and plasma insulin and was associated with smoking at baseline. An inverse correlation was found with albumin and total and HDL cholesterol. CRP was not associated with diabetes or cardiovascular disease but was significantly (P=0.015) higher in persons with (n=70) than without (n=385) dementia. During the 10-year follow-up, 61% (n=278) of the cohort died; half of the deaths were due to cardiovascular diseases. Mean CRP in survivors and nonsurvivors was 3.16 and 5.22 mg/L (P=0.017), respectively. After controlling for age and sex, baseline CRP (per 10 mg/L) significantly predicted the 10-year total mortality (risk ratio 1.20, 95% CI 1.08 to 1.32) and cardiovascular mortality (risk ratio 1.22, 95% CI 1.10 to 1.35). Predictive value was found in the 75-year-old cohort, but it was clearly attenuated in the 80- and 85-year-old cohorts. The results indicate that CRP is associated with several cardiovascular risk factors in the elderly. CRP alone predicts overall and cardiovascular mortality, but the prediction was significant in only the 75-year-old cohort.
Key Words: C-reactive protein • mortality • elderly
This article has been cited by other articles:
 |
|
 |
|
  D. I. Buckley, R. Fu, M. Freeman, K. Rogers, and M. Helfand C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force Ann Intern Med, October 6, 2009; 151(7): 483 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bochud, F. Marquant, P.-M. Marques-Vidal, P. Vollenweider, J. S. Beckmann, V. Mooser, F. Paccaud, and V. Rousson Association between C-Reactive Protein and Adiposity in Women J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3969 - 3977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Silverman, M. S. Beeri, J. Schmeidler, C. Rosendorff, G. Angelo, R. S. Mavris, H. T. Grossman, G. A. Elder, J. Carrion-Baralt, and R. West C-reactive protein and memory function suggest antagonistic pleiotropy in very old nondemented subjects Age Ageing, March 1, 2009; 38(2): 237 - 241. [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Hingorani, T. Shah, J. P. Casas, S. E. Humphries, and P. J. Talmud C-Reactive Protein and Coronary Heart Disease: Predictive Test or Therapeutic Target? Clin. Chem., February 1, 2009; 55(2): 239 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. de Ruijter, R. G J Westendorp, W. J J Assendelft, W. P J den Elzen, A. J M de Craen, S. le Cessie, and J. Gussekloo Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study BMJ, January 13, 2009; 338(jan08_2): a3083 - a3083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. H. Mizrahi, T. Blumstein, M. Arad, and A. Adunsky Serum Albumin Levels Predict Cognitive Impairment in Elderly Hip Fracture Patients American Journal of Alzheimer's Disease and Other Dementias, March 1, 2008; 23(1): 85 - 90. [Abstract] [PDF]
|
|
|
|
|
|
P. M Ridker High-Sensitivity C-Reactive Protein as a Predictor of All-Cause Mortality: Implications for Research and Patient Care Clin. Chem., February 1, 2008; 54(2): 234 - 237. [Full Text] [PDF]
|
|
|
|
|
|
W. Koenig, N. Khuseyinova, J. Baumert, and C. Meisinger Prospective Study of High-Sensitivity C-Reactive Protein as a Determinant of Mortality: Results from the MONICA/KORA Augsburg Cohort Study, 1984-1998 Clin. Chem., February 1, 2008; 54(2): 335 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Jenny, N. D. Yanez, B. M. Psaty, L. H. Kuller, C. H. Hirsch, and R. P. Tracy Inflammation Biomarkers and Near-Term Death in Older Men Am. J. Epidemiol., March 15, 2007; 165(6): 684 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Tice, A. Kanaya, T. Hue, S. Rubin, D. S. M. Buist, A. LaCroix, J. V. Lacey Jr, J. A. Cauley, S. Litwack, L. A. Brinton, et al. Risk Factors for Mortality in Middle-aged Women Arch Intern Med, December 11, 2006; 166(22): 2469 - 2477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Figaro, S. B. Kritchevsky, H. E. Resnick, R. I. Shorr, J. Butler, A. Shintani, B. W. Penninx, E. M. Simonsick, B. H. Goodpaster, A. B. Newman, et al. Diabetes, Inflammation, and Functional Decline in Older Adults: Findings from the Health, Aging and Body Composition (ABC) study. Diabetes Care, September 1, 2006; 29(9): 2039 - 2045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bayes, M. C. Pastor, J. Bonal, A. Foraster, and R. Romero Oxidative stress, inflammation and cardiovascular mortality in haemodialysis--role of seniority and intravenous ferrotherapy: analysis at 4 years of follow-up Nephrol. Dial. Transplant., April 1, 2006; 21(4): 984 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Eldrup, H. Sillesen, E. Prescott, and B. G. Nordestgaard Ankle brachial index, C-reactive protein, and central augmentation index to identify individuals with severe atherosclerosis Eur. Heart J., February 1, 2006; 27(3): 316 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Di Napoli, M. Schwaninger, R. Cappelli, E. Ceccarelli, G. Di Gianfilippo, C. Donati, H. C.A. Emsley, S. Forconi, S. J. Hopkins, L. Masotti, et al. Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke: A Statement for Health Care Professionals From the CRP Pooling Project Members Stroke, June 1, 2005; 36(6): 1316 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Kritchevsky, M. Cesari, and M. Pahor Inflammatory markers and cardiovascular health in older adults Cardiovasc Res, May 1, 2005; 66(2): 265 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Nicklas, T. You, and M. Pahor Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training Can. Med. Assoc. J., April 26, 2005; 172(9): 1199 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Dik, C. Jonker, C. E. Hack, J. H. Smit, H. C. Comijs, and P. Eikelenboom Serum inflammatory proteins and cognitive decline in older persons Neurology, April 26, 2005; 64(8): 1371 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Stuveling, S. J. L. Bakker, H. L. Hillege, P. E. de Jong, R. O. B. Gans, and D. de Zeeuw Biochemical risk markers: a novel area for better prediction of renal risk? Nephrol. Dial. Transplant., March 1, 2005; 20(3): 497 - 508. [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Fortmann, E. Ford, M. H. Criqui, A. R. Folsom, T. B. Harris, Y. Hong, T. A. Pearson, D. Siscovick, F. Vinicor, and P. F. Wilson CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Report From the Population Science Discussion Group Circulation, December 21, 2004; 110(25): e554 - e559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Engelhart, M. I. Geerlings, J. Meijer, A. Kiliaan, A. Ruitenberg, J. C. van Swieten, T. Stijnen, A. Hofman, J. C. M. Witteman, and M. M. B. Breteler Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study Arch Neurol, May 1, 2004; 61(5): 668 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J Nicklas, W. Ambrosius, S. P Messier, G. D Miller, B. W. Penninx, R. F Loeser, S. Palla, E. Bleecker, and M. Pahor Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial Am. J. Clinical Nutrition, April 1, 2004; 79(4): 544 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Danesh, J. G. Wheeler, G. M. Hirschfield, S. Eda, G. Eiriksdottir, A. Rumley, G. D.O. Lowe, M. B. Pepys, and V. Gudnason C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease N. Engl. J. Med., April 1, 2004; 350(14): 1387 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cesari, B. W. J. H. Penninx, M. Pahor, F. Lauretani, A. M. Corsi, G. R. Williams, J. M. Guralnik, and L. Ferrucci Inflammatory Markers and Physical Performance in Older Persons: The InCHIANTI Study J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2004; 59(3): M242 - M248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Tilvis, M. H. Kahonen-Vare, J. Jolkkonen, J. Valvanne, K. H. Pitkala, and T. E. Strandberg Predictors of Cognitive Decline and Mortality of Aged People Over a 10-Year Period J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2004; 59(3): M268 - M274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Engstrom, L. Stavenow, B. Hedblad, P. Lind, P. Tyden, L. Janzon, and F. Lindgarde Inflammation-Sensitive Plasma Proteins and Incidence of Myocardial Infarction in Men With Low Cardiovascular Risk Arterioscler Thromb Vasc Biol, December 1, 2003; 23(12): 2247 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cesari, B. W.J.H. Penninx, A. B. Newman, S. B. Kritchevsky, B. J. Nicklas, K. Sutton-Tyrrell, S. M. Rubin, J. Ding, E. M. Simonsick, T. B. Harris, et al. Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study Circulation, November 11, 2003; 108(19): 2317 - 2322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.J. Brull, N. Serrano, F. Zito, L. Jones, H.E. Montgomery, A. Rumley, P. Sharma, G.D.O. Lowe, M.J. World, S.E. Humphries, et al. Human CRP Gene Polymorphism Influences CRP Levels: Implications for the Prediction and Pathogenesis of Coronary Heart Disease Arterioscler Thromb Vasc Biol, November 1, 2003; 23(11): 2063 - 2069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Strandberg, K. H. Pitkala, K. H. Linnavuori, and R. S. Tilvis Impact of Viral and Bacterial Burden on Cognitive Impairment in Elderly Persons With Cardiovascular Diseases Stroke, September 1, 2003; 34(9): 2126 - 2131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. van der Meer, M. P. M. de Maat, A. J. Kiliaan, D. A. M. van der Kuip, A. Hofman, and J. C. M. Witteman The Value of C-Reactive Protein in Cardiovascular Risk Prediction: The Rotterdam Study Arch Intern Med, June 9, 2003; 163(11): 1323 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Ford, W. H. Giles, G. L. Myers, and D. M. Mannino Population Distribution of High-Sensitivity C-reactive Protein among US Men: Findings from National Health and Nutrition Examination Survey 1999-2000 Clin. Chem., April 1, 2003; 49(4): 686 - 690. [Full Text] [PDF]
|
|
|
|
|
|
R. S. Vasan, L. M. Sullivan, R. Roubenoff, C. A. Dinarello, T. Harris, E. J. Benjamin, D. B. Sawyer, D. Levy, P. W.F. Wilson, and R. B. D'Agostino Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction: The Framingham Heart Study Circulation, March 25, 2003; 107(11): 1486 - 1491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Engstrom, P. Lind, B. Hedblad, L. Stavenow, L. Janzon, and F. Lindgarde Long-Term Effects of Inflammation-Sensitive Plasma Proteins and Systolic Blood Pressure on Incidence of Stroke Stroke, December 1, 2002; 33(12): 2744 - 2749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kiechl, P. Werner, G. Egger, F. Oberhollenzer, M. Mayr, Q. Xu, W. Poewe, and J. Willeit Active and Passive Smoking, Chronic Infections, and the Risk of Carotid Atherosclerosis: Prospective Results From the Bruneck Study Stroke, September 1, 2002; 33(9): 2170 - 2176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Marques-Vidal, E. Mazoyer, V. Bongard, P. Gourdy, J.-B. Ruidavets, L. Drouet, and J. Ferrieres Prevalence of Insulin Resistance Syndrome in Southwestern France and Its Relationship With Inflammatory and Hemostatic Markers Diabetes Care, August 1, 2002; 25(8): 1371 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Visser, M. Pahor, D. R. Taaffe, B. H. Goodpaster, E. M. Simonsick, A. B. Newman, M. Nevitt, and T. B. Harris Relationship of Interleukin-6 and Tumor Necrosis Factor-{alpha} With Muscle Mass and Muscle Strength in Elderly Men and Women: The Health ABC Study J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2002; 57(5): M326 - 332. [Abstract] [Full Text]
|
|
|
|
|
|
R. Blackburn, P. Giral, E. Bruckert, J.-M. Andre, S. Gonbert, M. Bernard, M. J. Chapman, and G. Turpin Elevated C-Reactive Protein Constitutes an Independent Predictor of Advanced Carotid Plaques in Dyslipidemic Subjects Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1962 - 1968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pirro, J. Bergeron, G. R. Dagenais, P.-M. Bernard, B. Cantin, J.-P. Despres, and B. Lamarche Age and Duration of Follow-up as Modulators of the Risk for Ischemic Heart Disease Associated With High Plasma C-Reactive Protein Levels in Men Arch Intern Med, November 12, 2001; 161(20): 2474 - 2480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yamada, T. Gotoh, Y. Nakashima, K. Kayaba, S. Ishikawa, N. Nago, Y. Nakamura, Y. Itoh, and E. Kajii Distribution of Serum C-Reactive Protein and Its Association with Atherosclerotic Risk Factors in a Japanese Population : Jichi Medical School Cohort Study Am. J. Epidemiol., June 15, 2001; 153(12): 1183 - 1190. [Abstract] [Full Text] [PDF]
|
|